Brainreader A/S is a Danish A/S based in Aalborg Øst, operating in the Research and experimental development on natural sciences and engineering sector. Incorporated in 2011, the company has 2 employees and reported a gross profit of -DKK 1.2m in its latest annual filing.
| Gross profit | -1.2M DKK | +149% |
| EBITDA | -3.4M DKK | -6% |
| Net profit | -6.4M DKK | +5% |
| Total assets | 7.5M DKK | +18% |
| Equity | -12.5M DKK | +10% |
| Employees | 2 | — |
In its most recent annual report (2025), Brainreader A/S reported a gross profit of -DKK 1.2m. The figures on this page draw on 5 annual filings covering 2021 to 2025. The bottom line showed a net loss of DKK 6.4m.
At the end of 2025, current assets covered short-term debt 0.1 times. Brainreader A/S is one of 2 companies registered under Research and experimental development on natural sciences and engineering in Denmark.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Gross profit | -1,174 | -471 | -2,241 | -10,247 | -5,273 |
| Staff expenses | -2,195 | -2,705 | -4,642 | -6,452 | -5,575 |
| EBITDA | -3,369 | -3,176 | -6,883 | -16,698 | -10,848 |
| Depreciation & amort. | -789 | -750 | -648 | -496 | -1,012 |
| EBIT | -4,157 | -3,926 | -7,531 | -17,195 | -11,860 |
| Net financials | -2,338 | -2,960 | -1,866 | -532 | -240 |
| Profit before tax | -6,495 | -6,886 | -9,398 | -17,726 | -12,101 |
| Tax | -89 | -117 | -240 | -352 | -297 |
| Net profit | -6,406 | -6,769 | -9,157 | -17,374 | -11,804 |
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | 7,471 | 6,344 | 6,208 | 6,958 | 7,049 |
| Equity | -12,492 | -13,920 | -15,522 | -6,364 | -298 |
| Long-term debt | 3,965 | 17,915 | 17,707 | 11,948 | 5,502 |
| Short-term debt | 15,998 | 2,350 | 4,023 | 1,374 | 1,845 |
| Total debt | 19,963 | 20,264 | 21,730 | 13,323 | 7,347 |
28 financial ratios from the latest filing, each graded against companies in the same industry.
Net profit as a percentage of total assets — the return generated on the capital employed.
EBIT relative to total assets — the company's earning power before the effects of tax and financial leverage.
Shows how strongly fixed costs weigh on the gross result — a high ratio means fixed costs take only a small bite out of the earnings from basic operations.
The gross result as a share of revenue — how much of the revenue is left after variable costs to cover the company's fixed costs.
EBIT as a share of revenue — the share of revenue remaining as earnings once all operating costs are covered. A key measure of earning power.
The profit for the year as a share of revenue — the company's ability to turn revenue into profit.
Net profit as a percentage of equity — the return the owners earned on their invested capital this year.
Profit relative to net assets (total assets minus total debt) — the ability to generate earnings from the net asset base alone.
Current assets relative to short-term debt — the ability to settle short-term obligations with current assets alone. Around 150% is considered satisfactory from a credit perspective.
Current assets excluding inventory relative to short-term debt — whether the most liquid assets alone can cover the short-term obligations. A value of 1 or above signals a healthy liquidity position.
Cash relative to short-term debt — the ability to repay short-term obligations with cash alone.
Cash flow relative to profit — the ability to convert reported profits into accessible cash.
Current assets relative to equity — an indicator of the balance-sheet structure and of the company's short- and long-term financing. The healthy level is highly industry-dependent.
Fixed assets relative to long-term capital (equity plus long-term liabilities). Below 100% means the long-term capital finances more than just the fixed assets — a healthier liquidity position.
Equity as a share of total assets — the ability to absorb losses. Around 40% is considered satisfactory from a credit perspective.
Total debt relative to the balance-sheet total — the share of the assets financed by debt rather than equity.
Profit relative to debt — the ability to create earnings while operating with debt.
EBITDA relative to debt — how much operating earnings are available to service the debt.
The ability to pay the interest on the company's debt out of its earnings.
Financial expenses relative to total liabilities — the effective interest rate the company pays on its debt.
The return on assets minus the interest rate on debt. Positive means the company benefits from operating with debt; negative means the debt makes it worse off.
Debt relative to equity — the company's leverage. A higher value means heavier reliance on debt financing.
Total liabilities relative to equity — whether the company operates primarily on borrowed capital or on its own.
Total equity relative to the capital the owners contributed — how the equity has developed from its starting point.
The size of this year's increase or decrease in the company's debt.
Revenue relative to total assets — the ability to generate revenue from the asset base.
Revenue relative to inventory — how many times a year the inventory is sold and replaced. A low value can indicate weak sales or excess inventory.
The size of this year's increase or decrease in the company's equity.
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JH Chief Executive Officer | Chief Executive Officer | 2026 |
LC Management | Management | 2017 – 2020 |
DS Chief Executive Officer | Chief Executive Officer | 2011 – 2015 |
MF Chief Executive Officer | Chief Executive Officer | 2021 – 2026 |
LK Management | Management | 2015 – 2017 |
JA Management | Management | 2020 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (7) | ||
TT Board of Directors | Board of Directors | 2023 |
PT Chairman | Chairman | 2019 |
PD Board of Directors | Board of Directors | 2025 |
JH Board of Directors | Board of Directors | 2019 |
TH Board of Directors | Board of Directors | 2021 |
AR Board of Directors | Board of Directors | 2024 |
HB Board of Directors | Board of Directors | 2019 |
TS Board of Directors | Board of Directors | 2019 – 2021 |
SG Chairman | Chairman | 2018 – 2019 |
LC Board of Directors | Board of Directors | 2019 – 2019 |
JF Board of Directors | Board of Directors | 2013 – 2015 |
JS Board of Directors | Board of Directors | 2012 – 2013 |
CT Board of Directors | Board of Directors | 2016 – 2019 |
MD Chairman | Chairman | 2013 – 2018 |
SM Board of Directors | Board of Directors | 2015 – 2019 |
JA Chairman | Chairman | 2019 – 2019 |
| Shareholder | Type | Ownership | Votes | Registered |
|---|---|---|---|---|
| Company | 33.33–49.99% | 33.33–49.99% | 2021 | |
Norberg & Partners Brain Analysis AB | Company | 10–14.99% | 10–14.99% | 2024 |
Dahlgren Capital AB | Company | 5–9.99% | 5–9.99% | 2025 |
| Company | 5–9.99% | 5–9.99% | 2019 | |
| Company | 5–9.99% | 5–9.99% | 2025 | |
| Company | 5–9.99% | 5–9.99% | 2021 | |
| Company | 5–9.99% | 5–9.99% | 2019 | |
| Company | 10–14.99% | 10–14.99% | 2017 | |
| Company | 5–9.99% | 5–9.99% | 2019 | |
| Company | 10–14.99% | 10–14.99% | 2017 | |
| Company | 5–9.99% | 5–9.99% | 2017 | |
| Company | 66.67–89.99% | 66.67–89.99% | 2017 | |
| Company | 5–9.99% | 5–9.99% | 2016 | |
CBC Holding AB | Company | 15–19.99% | 15% | 2019 |
| Person | Role here | Other companies |
|---|---|---|
| Peter Thor Munck Birkmand | Chairman | 10 companiesMany roles |
| Henrik Bak | Board of Directors | 6 companiesMany roles |
| Lisbeth Christensen | Management | 3 companies |
| Morten Dahl Iversen | Chairman | 3 companies |
| Søren Munk | Board of Directors | 2 companies |
| Mads Fiig | Chief Executive Officer | 1 company |
| Lisbeth Kattenhøj | Management | 1 company |
| Jamila Ahdidan | Management | 1 company |
| Carsten Trads | Board of Directors | 1 company |